Expression of the breast cancer resistance protein (Bcrp1/Abcg2) in tissues from pregnant mice: Effects of pregnancy and correlations with nuclear receptors

American Journal of Physiology - Endocrinology and Metabolism

Volumn 291, Issue 6, 2006, Pages

  Wang, Honggang ^a   Wu, Xiaohui ^a   Hudkins, Kelly ^b   Mikheev, Andrei ^a   Zhang, Huixia ^a   Gupta, Anshul ^a   Unadkat, Jashvant D ^a   Mao, Qingcheng ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Abcg2; Bcrp1; Nuclear receptors; Pregnant mice; Tissue expression

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; BREAST CANCER RESISTANCE PROTEIN; CELL NUCLEUS RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; PROGESTERONE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GESTATIONAL AGE; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; CELL MEMBRANE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FEMALE; GESTATIONAL AGE; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IMMUNOHISTOCHEMISTRY; MICE; PLACENTA; PREGNANCY; PREGNANCY, ANIMAL; RECEPTORS, ARYL HYDROCARBON; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, PROGESTERONE; RNA, MESSENGER;

EID: 33845383376     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00193.2006     Document Type: Article

References (40)

1. Alpers CE, Hudkins KL, Gown AM, and Johnson RJ. Enhanced expression of "muscle-specific" actin in glomerulonephritis. Kidney Int 41: 1134-1142, 1992.
2. Cao J, Stieger B, Meier PJ, and Vore M. Expression of rat hepatic multidrug resistance-associated proteins and organic anion transporters in pregnancy. Am J Physiol Gastrointest Liver Physiol 283: G757-G766, 2002.
3. Charles GD, Bartels MJ, Gennings C, Zacharewski TR, Freshour NL, Bhaskar Gollapudi B, and Carney EW. Incorporation of S-9 activation into an ER-alpha transactivation assay. Reprod Toxicol 14: 207-216, 2000.
4. Daikoku T, Matsumoto H, Gupta RA, Das SK, Gassmann M, DuBois RN, and Dey SK. Expression of hypoxia-inducible factors in the periimplantation mouse uterus is regulated in a cell-specific and ovarian steroid hormone-dependent manner. Evidence for differential function of HIFs during early pregnancy. J Biol Chem 278: 7683-7691, 2003.
5. Doyle LA and Ross DD. Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2). Oncogene 22: 7340-7358, 2003.
6. Ebert B, Seidel A, and Lampen A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis 26: 1754-1763, 2005.
7. Ee PL, Kamalakaran S, Tonetti D, He X, Ross DD, and Beck WT. Identification of a novel estrogen response element in the breast cancer resistance protein (ABCG2) gene. Cancer Res 64: 1247-1251, 2004.
8. Ganapathy V, Prasad PD, Ganapathy ME, and Leibach FH. Placental transporters relevant to drug distribution across the maternal-fetal interface. J Pharmacol Exp Ther 294: 413-420, 2000.
9. Gil S, Saura R, Forestier F, and Farinotti R. P-glycoprotein expression of the human placenta during pregnancy. Placenta 26: 268-270, 2005.
10. Hasan A and Fischer B. Hormonal control of arylhydrocarbon receptor (AhR) expression in the preimplantation rabbit uterus. Anat Embryol (Berl) 204: 189-196, 2001.
11. Hu Z, Jin S, and Scotto KW. Transcriptional activation of the MDR1 gene by UV irradiation. Role of NF-Y and Sp1. J Biol Chem 275: 2979-2985, 2000.
12. Hudkins KL, Giachelli CM, Cui Y, Couser WG, Johnson RJ, and Alpers CE. Osteopontin expression in fetal and mature human kidney. J Am Soc Nephrol 10: 444-457, 1999.
13. Jonker JW, Buitelaar M, Wagenaar E, Van Der Valk MA, Scheffer GL, Scheper RJ, Plosch T, Kuipers F, Elferink RP, Rosing H, Beijnen JH, and Schinkel AH. The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria. Proc Natl Acad Sci USA 99: 15649-15654, 2002.
14. Jonker JW, Smit JW, Brinkhuis RF, Maliepaard M, Beijnen JH, Schellens JH, and Schinkel AH. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. J Natl Cancer Inst 92: 1651-1656, 2000.
15. Kast HR, Goodwin B, Tarr PT, Jones SA, Anisfeld AM, Stoltz CM, Tontonoz P, Kliewer S, Willson TM, and Edwards PA. Regulation of multidrug resistance-associated protein 2 (ABCC2) by the nuclear receptors pregnane X receptor, farnesoid X-activated receptor, and constitutive androstane receptor. J Biol Chem 277: 2908-2915, 2002.
16. Kioka N, Yamano Y, Komano T, and Ueda K. Heat-shock responsive elements in the induction of the multidrug resistance gene (MDR1). FEBS Lett 301: 37-40, 1992.
17. Krishnamurthy P, Ross DD, Nakanishi T, Bailey-Dell K, Zhou S, Mercer KE, Sarkadi B, Sorrentino BP, and Schuetz JD. The stem cell marker Bcrp/ABCG2 enhances hypoxic cell survival through interactions with heme. J Biol Chem 279: 24218-24225, 2004.
18. Kruijtzer CM, Beijnen JH, Rosing H, ten Bokkel Huinink WW, Schot M, Jewell RC, Paul EM, and Schellens JH. Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. J Clin Oncol 20: 2943-2950, 2002.
19. Leazer TM and Klaassen CD. The presence of xenobiotic transporters in rat placenta. Drug Metab Dispos 31: 153-167, 2003.
20. Maliepaard M, Scheffer GL, Faneyte IF, van Gastelen MA, Pijnenborg AC, Schinkel AH, van De Vijver MJ, Scheper RJ, and Schellens JH. Subcellular localization and distribution of the breast cancer resistance protein transporter in normal human tissues. Cancer Res 61: 3458-3464, 2001.
21. Mao Q and Unadkat JD. Role of the breast cancer resistance protein (ABCG2) in drug transport. Aaps J 7: E118-E133, 2005.
22. Mathias AA, Hitti J, and Unadkat JD. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. Am J Physiol Regul Integr Comp Physiol 289: R963-R969, 2005.
23. Mathias AA, Maggio-Price L, Lai Y, Gupta A, and Unadkat JD. Changes in pharmacokinetics of anti-HIV protease inhibitors during pregnancy: the role of CYP3A and P-glycoprotein. J Pharmacol Exp Ther 316: 1202-1209, 2006.
24. Merino G, van Herwaarden AE, Wagenaar E, Jonker JW, and Schinkel AH. Sex-dependent expression and activity of the ATP-binding cassette transporter breast cancer resistance protein (BCRP/ABCG2) in liver. Mol Pharmacol 67: 1765-1771, 2005.
25. Meyer zu Schwabedissen HE, Grube M, Dreisbach A, Jedlitschky G, Meissner K, Linnemann K, Fusch C, Ritter C, Volker U, and Kroemer HK. Epidermal growth factor (EGF) mediated activation of the MAP kinase cascade results in altered expression and function of ABCG2 (BCRP). Drug Metab Dispos 34: 524-533, 2006.
26. Meyer zu Schwabedissen HE, Jedlitschky G, Gratz M, Haenisch S, Linnemann K, Fusch C, Cascorbi I, and Kroemer HK. Variable expression of MRP2 (ABCC2) in human placenta: influence of gestational age and cellular differentiation. Drug Metab Dispos 33: 896-904, 2005.
27. Nakatsukasa H, Silverman JA, Gant TW, Evarts RP, and Thorgeirsson SS. Expression of multidrug resistance genes in rat liver during regeneration and after carbon tetrachloride intoxication. Hepatology 18: 1202-1207, 1993.
28. Ogihara H, Saito H, Shin BC, Terado T, Takenoshita S, Nagamachi Y, Inui K, and Takata K. Immuno-localization of H+/peptide cotransporter in rat digestive tract. Biochem Biophys Res Commun 220: 848-852, 1996.
29. Pang KS, Kong P, Terrell JA, and Billings RE. Metabolism of acetaminophen and phenacetin by isolated rat hepatocytes. A system in which the spatial organization inherent in the liver is disrupted. Drug Metab Dispos 13: 42-50, 1985.
30. Scotto KW. Transcriptional regulation of ABC drug transporters. Oncogene 22: 7496-7511, 2003.
31. Shanker YG and Rao AJ. Progesterone receptor expression in the human placenta. Mol Hum Reprod 5: 481-486, 1999.
32. Smit JW, Huisman MT, van Tellingen O, Wiltshire HR, and Schinkel AH. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. J Clin Invest 104: 1441-1447, 1999.
33. Spink DC, Katz BH, Hussain MM, Pentecost BT, Cao Z, and Spink BC. Estrogen regulates Ah responsiveness in MCF-7 breast cancer cells. Carcinogenesis 24: 1941-1950, 2003.
34. St-Pierre MV, Serrano MA, Macias RI, Dubs U, Hoechli M, Lauper U, Meier PJ, and Marin JJ. Expression of members of the multidrug resistance protein family in human term placenta. Am J Physiol Regul Integr Comp Physiol 279: R1495-R1503, 2000.
35. Sun M, Kingdom J, Baczyk D, Lye SJ, Matthews SG, and Gibb W. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. Placenta 27: 602-609, 2005.
36. Tanaka Y, Slitt AL, Leazer TM, Maher JM, and Klaassen CD. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp/Abcg2) in rats and mice. Biochem Biophys Res Commun 326: 181-187, 2005.
37. Unadkat JD, Dahlin A, and Vijay S. Placental drug transporters. Curr Drug Metab 5: 125-131, 2004.
38. Wang H, Zhou L, Gupta A, Vethanayagam RR, Zhang Y, Unadkat JD, and Mao Q. Regulation of BCRP/ABCG2 expression by progesterone and 17β-estradiol in human placental BeWo cells. Am J Physiol Endocrinol Metab 290: E798-E807, 2006.
39. Yasuda S, Itagaki S, Hirano T, and Iseki K. Expression level of ABCG2 in the placenta decreases from the mid stage to the end of gestation. Biosci Biotechnol Biochem 69: 1871-1876, 2005.
40. Young AM, Allen CE, and Audus KL. Efflux transporters of the human placenta. Adv Drug Deliv Rev 55: 125-132, 2003.